Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides
- 12 June 2006
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (9), 1237-1245
- https://doi.org/10.1097/01.aids.0000232230.96134.80
Abstract
Objectives: Establishment of an in vitro model to evaluate rectal safety and the efficacy of microbicide candidates. Design: An investigation and characterization of human colorectal explant culture for screening candidate microbicides to prevent rectal transmission of HIV-1 infection. Methods: Human colorectal explants were cultured at the liquid–air interface on gelfoam rafts. Phenotypic characterization of HIV-1 target cells was performed by fluorescence-activated cell sorter analysis. HIV-1 infection was determined by the measurement of p24 antigen release, viral RNA, and proviral DNA accumulation. Results: Colorectal explant CD4 T cells expressed higher CCR5 and CXCR4 levels compared with blood. Minor differences between the rectal and sigmoid colon were observed with a trend for slightly higher CCR5 and HLA-DR expression in cells from the sigmoid colon. Favourable culture conditions were established for colorectal tissue. Although tissue structure degenerated with time, CD4: CD8 cell ratios remained constant, and tissue supported productive HIV-1 infection. The ability of candidate microbicides to inhibit R5 HIV-1 infection was evaluated. Polyanion candidates, PRO2000 and dextrin sulphate, provided 99% protection at 1 μg/ml and 1 mg/ml, respectively, equivalent to 1/5000 and 1/40 of the vaginal formulations. The nucleotide reverse transcriptase inhibitor (NRTI) 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) provided protection at concentrations 1000-fold lower (10 μg/ml) than the proposed vaginal formulation (1%). Furthermore, non-NRTI UC-781 and TMC-120 provided greater than 99% inhibition at 3.3 or 0.33 μg/ml, respectively. No products demonstrated toxicity to rectal mucosa at inhibitory concentrations. Conclusion: Colorectal explant culture was shown to be a useful tool for the preclinical evaluation of potential microbicides. The data suggest that rectally applied microbicides might provide protection from HIV-1 transmission.Keywords
This publication has 25 references indexed in Scilit:
- Recent trends in diagnoses of HIV and other sexually transmitted infections in England and Wales among men who have sex with menSexually Transmitted Infections, 2004
- Lubricants containing N-9 may enhance rectal transmission of HIV and other STIsContraception, 2004
- Relative Safety of Sexual Lubricants for Rectal IntercourseSexually Transmitted Diseases, 2004
- A Preponderance of CCR5+CXCR4+Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2001
- Evaluation of a Low-Dose Nonoxynol-9 Gel for the Prevention of Sexually Transmitted DiseasesSexually Transmitted Diseases, 2001
- Anal intercourse among young low-income women in California: an overlooked risk factor for HIV?AIDS, 2001
- Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissueAIDS, 2000
- Per-Contact Risk of Human Immunodificiency Virus Tramnsmision between Male Sexual PartnersAmerican Journal of Epidemiology, 1999
- Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infectionEuropean Journal of Immunology, 1999
- Nonoxynol-9 enhances rectal infection by herpes simplex virus in miceContraception, 1998